+ 7 (495) 684-04-00

Tag: Biotech

Friday Investment Talk: Biotech, 2022 Forecast, M&A, Fusion Energy

Biotech indexes are not created equally. XBI is an equal weighted smaller cap index, while IBB is market cap with large weightings in COVID vaccine producers. Their results were very divergent in 2021. Markets have grown substantially in 2021 on the back of loose monetary and fiscal policy in the US (and around the world). …

Friday Investment Talk: Biotech, 2022 Forecast, M&A, Fusion Energy Read More »

Biotech – Analysis and Outlook

AVC have focused on the two leading Biotech ETFs over the last few years, but it has been a tough year. We follow XBI and IBB. XBI is SPDR S&P Biotech, and IBB is iShares Biotechnology.

Italian Engineering

engineering biotech
A relatively new biotech company is likely to go back to new highs before its next earnings report. Stars are aligned for the long term growth of this company also.
To access this post, you must purchase Subscription Plan – AVC Pro.

Friday Investment Talk: Hydrogen, Biogen’s Alzheimer Drug and Market Action

FIT - PLUG
Hydrogen fuel technology companies are reviewed. Biogen stock looks vulnerable as FDA approval of its new Alzheimer drug attracts criticism. Stocks hit highs, but not very convincingly.

Stock Trade: Month End Catalyst

Diabetes Catalyst
With this stock out of favor yet showing some stable base building, investors are ignoring major catalyst occurring before month end.
To access this post, you must purchase Subscription Plan – AVC Pro.

Stock Idea: FDA Softens

Biogen's new Alzheimer's, drug approval has investors pondering whether this is enough of a change in mindset to reshape opinions about gene editing companies. Bets are being placed in the options market.
To access this post, you must purchase Subscription Plan – AVC Pro.

Friday Investment Talk: Semiconductors, Inflation, Bonds and Biotech

Friday Investment Talk Feb19
The global semiconductor shortage calls for capital investments. Commodity inflation is here. CPIs are low still, but long bonds sell off. Biotech is a sweet spot.

Stock Research: Women Suffer More

Womens Health and Lupus
A timely play in a company focused on autoimmune disease detection for diseases disproportionately affecting women.
To access this post, you must purchase Subscription Plan – AVC Pro.

Stock Research: Making Waves in Oncology

A very early stage biotech opportunity with links to big pharma. We are seeing small scattered call buying today.
To access this post, you must purchase Subscription Plan – AVC Pro.

Friday Investment Talk: Black Friday, Biotech, Solar Stocks, and Gold

Black Friday Sales are expected to be dominated by online shopping with overall sales increasing by 5% from 2019. Is this a low estimate? Biotech and Solar ETFs breakout, while gold broke down this week.

For Whom

Our Expertise

Our Solutions

This information is not an individual investment recommendation, and the financial instruments or transactions mentioned in it may not correspond to your investment profile and investment goals (expectations). It is your task to determine whether a financial instrument or transaction matches your interests, investment objectives, investment horizon and acceptable risk level. AVC Adisvory, Inc. and its affiliates are not liable for possible losses in case of making transactions or investing in the financial instruments mentioned in this information, and do not recommend using this information as the only source of information when making an investment decision.

Twitter Facebook Linkedin-in Youtube Telegram-plane
Scroll to Top